Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial

References

• Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127–41.
   PubMed Web of Science ®Google Scholar
• Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Jpn J Clin Oncol 2015;45:390–401.
   PubMed Web of Science ®Google Scholar
• de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol 2012;56(Suppl1):S75–87.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
   PubMed Web of Science ®Google Scholar
• Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: A population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115–19.
   PubMed Web of Science ®Google Scholar
• Kim GA, Shim JH, Yoon SM, Jung J, Kim JH, Ryu MH, et al. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis. J Vasc Interv Radiol 2015;26:320–9.e326.
   PubMed Web of Science ®Google Scholar
• Han KH, Seong J, Kim JK, Ahn SH, Lee do Y, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008;113:995–1003.
   PubMed Web of Science ®Google Scholar
• Choi C, Koom WS, Kim TH, Yoon SM, Kim JH, Lee HS, et al. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2014;90:1051–60.
   PubMed Web of Science ®Google Scholar
• Yu JI, Park HC, Lim do H, Kim CJ, Oh D, Yoo BC, et al. Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinoma. J Korean Med Sci 2012;27:736–43.
   PubMed Web of Science ®Google Scholar
• Kim SW, Oh D, Park HC, Lim do H, Shin SW, Cho SK, et al. Transcatheter arterial chemoembolization and radiation therapy for treatment-naive patients with locally advanced hepatocellular carcinoma. Radiat Oncol J 2014;32:14–22.
   PubMedGoogle Scholar
• Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys 2012;82:2004–11.
   PubMed Web of Science ®Google Scholar
• Yu JI, Park HC, Lim do H, Park W, Yoo BC, Paik SW, et al. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy. J Korean Med Sci 2011;26:1014–22.
   PubMed Web of Science ®Google Scholar
• Jo IY, Son SH, Kim M, Sung SY, Won YK, Kang HJ, et al. Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma. Radiat Oncol J 2015;33:179–87.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487–97.
   PubMed Web of Science ®Google Scholar
• Hurwitz M, Stauffer P. Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care. Semin Oncol 2014;41:714–29.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020–2.
   PubMed Web of Science ®Google Scholar
• Yu JI, Kim JS, Park HC, Lim DH, Han YY, Lim HC, et al. Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma. Br J Radiol 2013;86:20120221.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52–60.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v.4.0, 2010. Available at http://evs.nci.nih.gov/ftp1/CTCAE/About.html
   Google Scholar
• Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005;103:2419–26.
   PubMed Web of Science ®Google Scholar
• Klein J, Dawson LA. Hepatocellular carcinoma radiation therapy: Review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 2013;87:22–32.
   PubMed Web of Science ®Google Scholar
• Yu JI, Park HC. Considerations for radiation therapy in hepatocellular carcinoma: The radiation oncologists’ perspective. Dig Dis 2014;32:755–63.
   PubMed Web of Science ®Google Scholar
• Yeh SA, Chen YS, Perng DS. The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. J Radiat Res 2015;56:325–31.
   PubMed Web of Science ®Google Scholar
• Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RK, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 2013;31:1631–9.
   PubMed Web of Science ®Google Scholar
• Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002;54:150–5.
   PubMed Web of Science ®Google Scholar
• Yoon H, Oh D, Park HC, Kang SW, Han Y, Lim DH, et al. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma. Strahlenther Onkol 2013;189:541–6.
   PubMed Web of Science ®Google Scholar
• Yu JI, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW. Child–Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: Aspects of gastroduodenal complications. Tumori 2014;100:645–51.
   PubMed Web of Science ®Google Scholar
• Hocquelet A, Balageas P, Laurent C, Blanc JF, Frulio N, Salut C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia 2015;31:749–57.
   PubMed Web of Science ®Google Scholar
• Huang H, Liang P, Yu XL, Cheng ZG, Han ZY, Yu J, et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia 2015;31:40–7.
   PubMed Web of Science ®Google Scholar
• Zhai H, Liang P, Yu XL, Cheng Z, Han ZY, Liu F, et al. Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: An analysis of 11 cases. Int J Hyperthermia 2015:31:863–8.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76:S10–19.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC, Aleman A, Kelfkens G, Kromhout H, Van Leeuwen FE, Savelkoul HF, et al. Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits. Int J Hyperthermia 2011;27:399–404.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G. Some aspects of quality management in deep regional hyperthermia. Int J Hyperthermia 2012;28:562–9.
   PubMed Web of Science ®Google Scholar
• Noh JM, Kim HY, Park HC, Lee SH, Kim YS, Hong SB, et al. In vivo verification of regional hyperthermia in the liver. Radiat Oncol J 2014;32:256–61.
   PubMedGoogle Scholar
• Kalogeridi MA, Zygogianni A, Kyrgias G, Kouvaris J, Chatziioannou S, Kelekis N, et al. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World J Hepatol 2015;7:101–12.
   PubMedGoogle Scholar